home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

278 rows where filing_period = "second_quarter", filing_year = 2010 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 278 ✖

filing_year 1

  • 2010 · 278 ✖

filing_period 1

  • second_quarter · 278 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
945907 ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH 9fc76cee-6906-4c38-a406-8d318a0600ce Q2 ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH 113 ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH 2010 second_quarter MED FEDERAL FUNDING FOR THE NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING AT THE NATIONAL INSTITUTES OF HEALTH HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-06-07T11:00:43.720000-04:00
946635 HOLLAND & KNIGHT LLP f6719352-3cf9-4fc3-a8ef-8544abe336fa Q2 HOLLAND & KNIGHT LLP 18466 ALLIANCE FOR REGENERATIVE MEDICINE 2010 second_quarter MED Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 60000   0 0 2010-06-28T11:25:48.423000-04:00
946684 HOLLAND & KNIGHT LLP ede8552c-661c-47d8-bae8-7235d595695a Q2 HOLLAND & KNIGHT LLP 18466 Q THERAPEUTICS, INC. 2010 second_quarter MED Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-06-28T12:45:15.273000-04:00
946815 HOLLAND & KNIGHT LLP 6ef5ef96-3574-4f95-bd57-02bfdb1eebb8 Q2 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2010 second_quarter MED Labor, HHS, Education Appropriations bills; hematology and hematology/oncology public health and research issues; Health Reform Legislation; HR 1230 Bone Marrow Failure Disease Research and Treatment Act. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2010-06-29T13:22:49.667000-04:00
946821 HOLLAND & KNIGHT LLP d67793e3-bf4d-4bbd-9971-337eb79870ea Q2 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2010 second_quarter MED Biomedical Research; CDC Hemophilia program; HR 4846 SAFE Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2010-06-29T13:27:54.447000-04:00
946826 HOLLAND & KNIGHT LLP 8015af12-d5a5-4d56-9dee-05caaf2913c8 Q2 HOLLAND & KNIGHT LLP 18466 AABB 2010 second_quarter MED Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-06-29T13:34:00.557000-04:00
947168 MIKE SLOTZNICK bf02adb1-a242-46ff-bb59-1d2abd4b94b4 2T MIKE SLOTZNICK 400457200 PHARMACEUTICAL MARKETING RESEARCH GROUP, INC. 2010 second_quarter MED Physician Payments Sunshine Act of 2009 (S. 301, H.R. 3138) -- applicability to survey research activities. HOUSE OF REPRESENTATIVES,SENATE     0 1 2010-07-01T22:14:59.303000-04:00
947203 MARSHALL BRACHMAN af01a255-35f8-459a-b89e-8dd1a33c66d6 Q2 MARSHALL BRACHMAN 6848 CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE 2010 second_quarter MED support HR 1293/S. 1338 equivalent in 111th Congress reverse cardiac catheterization practice expense cuts HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2010-07-02T10:19:13.267000-04:00
947237 MARSHALL BRACHMAN a29b5ca6-1a1c-47c3-85b5-fff313e2c594 Q2 MARSHALL BRACHMAN 6848 ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC 2010 second_quarter MED oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging in HR 3200 and equivalent Senate legislation; support HR 4173 to reverse cuts in 2010 PFS rule HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2010-07-02T10:51:26.940000-04:00
947256 MARSHALL BRACHMAN 72f669c8-9a74-42eb-a8e3-b420dffda3eb Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2010 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2010-07-02T11:09:31.067000-04:00
947262 FRANCIS EDWARD & CRONIN, INC. 5313473c-fd2a-4a5e-a6c8-b5e7b4c31d0c Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2010 second_quarter MED Legislation and issues related to Alzheimer's Disease Research Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 10000   0 0 2010-07-02T11:16:26.217000-04:00
947470 LAWRENCE J. SMITH, P.A. 0d831fa8-7c62-455b-b252-121503725b0d Q2 LAWRENCE J. SMITH, P.A. 35775 NATIONWIDE LABORATORY SERVICES 2010 second_quarter MED Medicare - End Stage Renal Disease. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-06T11:10:05.203000-04:00
947514 BOLTON-ST. JOHNS, LLC 2415b7d2-8e77-45a5-b895-1532fb9b36a2 Q2 BOLTON-ST. JOHNS, LLC 302290 AMDEC FOUNDATION, INC. 2010 second_quarter MED Issues relating to grant funding for biomedical research. HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-06T12:38:08.197000-04:00
947590 THE HARRIS FIRM 08fb4bc9-80d5-4e17-b304-f189697e367b Q2 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2010 second_quarter MED Regarding funding for FY 11 pertaining to software communication system for chronic disease management HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-06T15:04:51.603000-04:00
947611 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 1f8cb3fc-fcd7-4720-8498-af84be1acfd8 Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2010 second_quarter MED all issues related to pharmaceutical labeling   25000   0 0 2010-07-06T15:28:55.313000-04:00
947689 ASSN OF MEDICAL DEVICE REPROCESSORS 48efbc1a-1358-444a-b606-67fe3c15bb0f Q2 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2010 second_quarter MED Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2010-07-07T10:15:59.910000-04:00
947761 MAYO CLINIC dbcaa65a-f060-4e84-b0f4-232bdd845223 Q2 MAYO CLINIC 400270238 MAYO CLINIC 2010 second_quarter MED Cancer research Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2010-07-07T12:58:08.293000-04:00
947880 FEDERAL SOLUTIONS, LLC c7090d6f-4708-4564-ac13-4c513a8acade Q2 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2010 second_quarter MED Labor/HHS/Education Appropriations Bill, 2010: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-07T15:05:52.667000-04:00
947887 FEDERAL SOLUTIONS, LLC c5bed79a-3e90-41b1-b9fc-d732f88ff5f7 Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2010 second_quarter MED Labor/HHS/Education Appropriations Bill, 2010: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Veterans Affairs, Dept of (VA) 50000   0 0 2010-07-07T15:08:56.637000-04:00
947931 AMERICAN COLLEGE OF CLINICAL PHARMACY d58de490-c00e-4e6b-a11d-d2322c7f8ab8 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2010 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   54750 0 0 2010-07-07T15:29:08.027000-04:00
948595 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8caa2244-5361-49ca-915f-3c22ec9ab171 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PARENT PROJECT MUSCULAR DYSTROPHY 2010 second_quarter MED Reauthorization for the Muscular Dystrophy Care Act Funding for CDC, NIH, HHS, and FDA related to Muscular Dystrophy and other health research HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2010-07-08T18:06:53.973000-04:00
949309 CAPITOL CONSULTING GROUP, LLC 8e9e8e5a-45c5-46a3-a4f9-17329cb5b0b4 Q2 CAPITOL CONSULTING GROUP, LLC 400366700 EMERGENCY PRESERVATION AND RESUSITATION TECHNOLOGIES, INC 2010 second_quarter MED FY11 defense appropriations bill, medical research and development project regarding emergency profound hyperthermia for advanced casualty care HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-10T08:33:13.317000-04:00
949317 CAPITOL CONSULTING GROUP, LLC 3dd4db9a-0a4d-40ff-8f0b-0acb304a297c Q2 CAPITOL CONSULTING GROUP, LLC 400366700 FLAGSHIP GOVERNMENT RELATIONS, INCORPORATED 2010 second_quarter MED FY 11 defense appropriations bill, medical research and development HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-10T09:00:16.597000-04:00
949322 CAPITOL CONSULTING GROUP, LLC ee77665d-475d-4b06-83d6-1e21bddd1446 Q2 CAPITOL CONSULTING GROUP, LLC 400366700 LIFECELL CORPORATION 2010 second_quarter MED FY11 defense appropriations bill, Army medical research and development project HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-10T09:24:19.207000-04:00
949578 THE CJR GROUP, INC. 32699647-9669-4b65-84f7-697e86e17959 Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2010 second_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-12T10:32:30.850000-04:00
949610 NATIONAL VENTURE CAPITAL ASSOCIATION 5b0370fb-3e6d-4e6a-b236-bb60fa80a07b Q2 NATIONAL VENTURE CAPITAL ASSOCIATION 21687 NATIONAL VENTURE CAPITAL ASSOCIATION 2010 second_quarter MED FDA Preemption: S540 and HR1346 Medical Device Safety Act of 2009 Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office   826066 0 0 2010-07-12T11:14:31.597000-04:00
949899 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 9723f837-9546-4d14-8e11-50adb6b937b0 Q2 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 BIOCRYST PHARMACEUTICALS, INC. 2010 second_quarter MED Federal response to the H1N1 influenze pandemic and overall prepardness HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-12T14:15:28.747000-04:00
950071 BEN BARNES GROUP LP 547958b1-776d-4a2c-8b88-e6a99a36535d Q2 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2010 second_quarter MED Assistance with issues relating to medical research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-12T15:46:55.717000-04:00
950259 PREVENT BLINDNESS 88bb6598-e936-497a-bab2-10e65c3d0a75 Q2 PREVENT BLINDNESS 78312 PREVENT BLINDNESS 2010 second_quarter MED Eye Disease; Treatment and Prevention of Blindness and Vision Loss Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   44923 0 0 2010-07-12T17:36:04.920000-04:00
950395 LEE & SMITH, PC 799e8bd3-1fa7-47ef-a9c2-604630aa3919 Q2 LEE & SMITH, PC 22440 NORTH DAKOTA STATE UNIVERSITY (NDSU) 2010 second_quarter MED (1) House and Senate FY2011 Labor, Health and Human Services Appropriations Bill (still unnumbered), U.S. Department of Health and Human Services, Health Resources Services Administration (HRSA); Issue: Biomedical Research Infrastructure Improvement at North Dakota State University. Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-13T01:45:25.427000-04:00
951098 PAUL MARCONE & ASSOCIATES, LLC d1e10d23-3cf0-418a-a93c-1ca92b5422a1 Q2 PAUL MARCONE & ASSOCIATES, LLC 283732 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 2010 second_quarter MED Getting Congress to stop federal funding of a specific grant awarded by NASA for radiation studies involving the use of live squirrel monkeys and designed to predict radiation risks for astronauts during deep space travel. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2010-07-13T13:17:20.250000-04:00
951495 BEN BARNES GROUP LP ea60a9e4-6e40-4eeb-8aae-b071c7098e2c Q2 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2010 second_quarter MED Issues relating to medical research HOUSE OF REPRESENTATIVES,SENATE 13400   0 0 2010-07-13T14:59:01.860000-04:00
951689 TOURETTE ASSOCIATION OF AMERICA 87416cb9-9402-4d9c-97bf-bb83f6c09426 Q2 TOURETTE ASSOCIATION OF AMERICA 87494 TOURETTE ASSOCIATION OF AMERICA 2010 second_quarter MED Tourette Syndrome Research Centers For Disease Control & Prevention (CDC),Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Social Security Administration (SSA)   70000 0 0 2010-07-13T15:51:15.017000-04:00
951716 PARRY, ROMANI, DECONCINI & SYMMS 077103fb-fa15-437f-9d8b-e38e393ca262 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2010 second_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010 - Support funding for medical treatment for HIV positive patients. Not introduced. Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare. Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-13T15:56:02.780000-04:00
951896 DENNY MILLER ASSOCIATES d4eb10c2-aaee-4871-bd6e-66e529e1bc48 Q2 DENNY MILLER ASSOCIATES 25328 ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER 2010 second_quarter MED FY2011 Dept. of Labor, Health and Human Services Appropriations, Title II, provisions related to mental health projects. FY2011 Dept. of Defense Appropriations, Title IV, provisions related to Army medical research. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-13T16:47:55.553000-04:00
951913 DENNY MILLER ASSOCIATES 897e4ade-0e49-4885-9724-e8b542675ad5 Q2 DENNY MILLER ASSOCIATES 25328 STB CORPORATION 2010 second_quarter MED FY2011 Dept. of Defense Appropriations, TItle IV, RDT&E, issues pertaining to medical advanced technology FY2009 DOD Appropriations, P.L. 111-32, issues pertaining to medical advanced technology HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-13T16:54:03.647000-04:00
951924 MEHLMAN CONSULTING, INC. 10f277a0-633e-4e8d-8a07-65792150dbf6 Q2 MEHLMAN CONSULTING, INC. 284950 AMERICAN CLINICAL LABORATORY ASSOCIATION 2010 second_quarter MED Health reform law implementation issues including application of medical device tax to clinical laboratory tests and cut to laboratory fee schedule update. H.R. 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010: health care provisions including physician payment (SGR), FMAP and Cobra. H.R. 5440, Genomics and Personalized Medicine Act of 2010: FDA oversight of laboratory developed tests (LDTs). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-07-13T16:56:41.587000-04:00
952352 WHITMER & WORRALL, LLC 7bfd6eec-2371-44d3-9399-92ab80dab17b Q2 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2010 second_quarter MED Issues related to Traumatic Brain Injury (TBI). HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-14T10:36:04.777000-04:00
952368 RAY C CULVER III e2a199b4-fba5-4f46-a9b2-3e9bec9c4c1e Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2010 second_quarter MED Funding for USDA Agricultural Research Service human nutrition centers in the FY2011 Agricultural Appropriations bill HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-14T10:44:13.180000-04:00
953001 O'NEILL, ATHY & CASEY, P.C. 26bdbbad-0ef5-4d00-a57f-37f5d9c041d6 Q2 O'NEILL, ATHY & CASEY, P.C. 42752 MASS GENERAL BRIGHAM 2010 second_quarter MED Funding for federally-sponsored medical research American Recovery and Reinvestment Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),White House Office 150000   0 0 2010-07-14T14:24:50.963000-04:00
953709 M.J. SIMON & COMPANY, LLC 9b609840-0046-4cd1-bf0e-210a3fd611b0 Q2 M.J. SIMON & COMPANY, LLC 40026223 AXOGEN INC. 2010 second_quarter MED Food and Drug Act Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2010-07-14T21:23:04.220000-04:00
953851 KSCW, INC. bbdc417d-1ead-4442-bf03-532d97a59e31 Q2 KSCW, INC. 21596 INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS 2010 second_quarter MED HR1346, S540 Medical Device Safety Act of 2009: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. HOUSE OF REPRESENTATIVES 10000   0 0 2010-07-15T08:59:53.433000-04:00
953931 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH d4f5634c-ce45-4e29-9814-f2edd679a885 Q2 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2010 second_quarter MED Support for the National Institutes of Health; Support for the National Eye Institute; Support for medical research programs at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   76000 0 0 2010-07-15T10:32:50.107000-04:00
954229 BUTZEL LONG TIGHE PATTON PLLC 4d7f4303-8df5-4661-bcd1-51c18e5d0497 Q2 BUTZEL LONG TIGHE PATTON PLLC 45298 ASPEN MEDICAL USA, INC. 2010 second_quarter MED Health care services to Guam, Pacific Islands, and DOD. Health care services to DOD. HOUSE OF REPRESENTATIVES,Navy, Dept of 20000   0 0 2010-07-15T11:38:16.950000-04:00
954251 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 722c41c4-d7f5-4f4e-a0bd-69294b4e0b35 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 COOLEY'S ANEMIA FOUNDATION 2010 second_quarter MED Drug review and approval process Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-15T11:43:30.310000-04:00
954432 PARALYZED VETERANS OF AMERICA 5fa83626-49d9-4927-a1b9-0297658e6ec2 Q2 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2010 second_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   85026 0 0 2010-07-15T12:51:10.357000-04:00
954451 POLICY DIRECTIONS INC. 5a3ba48b-df90-4a78-9914-44a79c2e0358 Q2 POLICY DIRECTIONS INC. 31747 ADVANCED LIFE SCIENCES 2010 second_quarter MED FDA regulatory pathway for new antibiotic medicines. HR 2400, Strategies to Address Antimicrobial Resistance Act, portions related to introduction of and regulatory policy of new antimicrobial candidates. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-15T12:53:14.060000-04:00
954507 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 86805fa7-8c01-4cf2-9ee4-26f62cce64d6 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2010 second_quarter MED Appropriations and Authorization legislation for FY 2011 in health care Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2010-07-15T13:12:42.620000-04:00
954591 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f18bdd6b-f647-47a0-8870-fad432062094 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2010 second_quarter MED No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease HR 1230, Bone Marrow Failure Disease Research and Treatment Act Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2010-07-15T13:33:11.433000-04:00
954609 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 47197431-5a4c-4c68-a0c7-4bf7bf8c8c40 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2010 second_quarter MED No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, Tuberous Sclerosis No Bill#, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2010-07-15T13:35:17.747000-04:00
954664 PARRY, ROMANI, DECONCINI & SYMMS ff8eb4b6-07da-4bb3-b2e7-426e172b5e50 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2010 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T13:42:33.073000-04:00
954681 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a6191ad1-13fa-4303-88b7-3db324eb6d20 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 U.S. SOCCER FOUNDATION 2010 second_quarter MED Congressional Soccer Caucus Federal grants for obesity prevention and gang prevention No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, anti-obesity programs Corporation for Natl & Community Service,Defense, Dept of (DOD),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE 10000   0 0 2010-07-15T13:44:37.777000-04:00
954709 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 6d317398-d061-4cdc-a8be-654217272706 Q2 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2010 second_quarter MED H.R. 1 American Recovery and Reinvestment Act of 2009 Stark Self-Referral Related Issues Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts Elimination of SGR Formula Under Medicare; HR 3962, the Affordable Health Care for America Act Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE   52400 0 0 2010-07-15T13:50:58.240000-04:00
954722 DALRYMPLE & ASSOCIATES, LLC f675458d-8d65-47bb-bbc8-4d18515d159c Q2 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2010 second_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 47000   0 0 2010-07-15T13:53:53.497000-04:00
954749 DALRYMPLE & ASSOCIATES, LLC 07e5af63-5cc4-4589-abd5-366b151e8ae3 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2010 second_quarter MED Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 47000   0 0 2010-07-15T13:59:03.513000-04:00
954757 PARRY, ROMANI, DECONCINI & SYMMS 831cb22b-4b9e-4a79-8680-28bb40ebc165 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2010 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T14:00:06.603000-04:00
954761 DALRYMPLE & ASSOCIATES, LLC 25bcabbf-7fff-4749-acb5-73852a10a2c1 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 PULMATRIX, INC. 2010 second_quarter MED Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Executive Office of the President (EOP),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS) 16000   0 0 2010-07-15T14:02:09.687000-04:00
954826 PARRY, ROMANI, DECONCINI & SYMMS a7ec478c-527a-4edd-89ef-cdcd59d0ce29 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2010 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T14:16:32.360000-04:00
955100 PARRY, ROMANI, DECONCINI & SYMMS 4cc586da-bc2c-41cc-bed8-dbc8307055d0 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2010 second_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T15:53:07.367000-04:00
955111 CHARLIE MCBRIDE ASSOCIATES efbdf795-82dc-4063-a54e-37b3a55c8d51 Q2 CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2010 second_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 7200   0 0 2010-07-15T15:55:12.583000-04:00
955619 THE WHITAKER GROUP, INC 830ed7d2-3e3d-4190-9f09-9152b0330b7d Q2 THE WHITAKER GROUP, INC 312598 SAFE BLOOD INTERNATIONAL FOUNDATION FORMERLY SAFE BLOOD FOR AFRICA FOUNDATION 2010 second_quarter MED To promote interest in, and support for, funding for blood safety programs, such as those conducted by Safe Blood for Africa Foundation, as an important means of preventing the spread of HIV/AIDS and other blood-borne diseases internationally, but primarily in Sub-Saharan Africa. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-15T17:37:55.410000-04:00
955681 CALIFORNIA LIFE SCIENCES b2ff8333-905f-41f6-a421-384f7c521321 Q2 CALIFORNIA LIFE SCIENCES 7758 CALIFORNIA LIFE SCIENCES 2010 second_quarter MED Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education and strategic stockpilefunding and preparation. HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2010-07-15T18:13:49.037000-04:00
955707 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 04404cbd-1126-4a76-9fb8-48ac124db40a Q2 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2010 second_quarter MED No bill #: Educate members and staff about occupational therapy research. Bureau of Labor Statistics (BLS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office   110000 0 0 2010-07-15T18:37:38.943000-04:00
956095 VAN SCOYOC ASSOCIATES 1ada50f1-709f-4e69-8cbf-91b5b7139a48 Q2 VAN SCOYOC ASSOCIATES 39837 BOSTON BIOCOM LLC 2010 second_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, Biomedical research issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-16T08:06:51.873000-04:00
956354 THE PETRIZZO GROUP, INC. 1df2a935-5831-44db-838d-b1d892b4467f Q2 THE PETRIZZO GROUP, INC. 305932 AGIOS PHARMACEUTICALS, INC. 2010 second_quarter MED Advance proposal for federal funding in the FY 2011 Defense Appropriations bill for cancer metabolism drug discovery that will bring therapeutic hope to service men and women who are suffering from Acut Myeloid Leukemia and brain cancer (gliomas). HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-16T10:54:01.890000-04:00
956400 THE PETRIZZO GROUP, INC. 4f1a360d-939a-4166-b19c-22b3a37afb70 Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2010 second_quarter MED Advocated for federal funding in the FY 2011 Labor HHS Appropriations bill for the Allen Institute Human Brain Atlas Project, which will create a comprehensive 3-dimensional map detailing gene expression in the human brain. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-07-16T11:00:14.877000-04:00
956402 MANATOS & MANATOS f8118a11-309b-4a10-8a37-7a9fb2293a9e Q2 MANATOS & MANATOS 23634 RWD TECHNOLOGIES 2010 second_quarter MED Congressional or Executive Branch actions that affect the health care industry, particularly with regard to the elimination of waste in hospital procedures. HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-16T11:01:16.017000-04:00
956632 FOWLER COMMUNICATIONS INC 96b76a24-45c8-4da3-9f7b-9b6a23b577dc Q2 FOWLER COMMUNICATIONS INC 15257 SOUTH CAROLINA MEDICAL ASSOCIATION 2010 second_quarter MED amendment to existing ERISA authorizing a different distribution of assets in event of the dissolution of a multiple entitlement association HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-16T11:44:40.937000-04:00
956714 UNIVERSITY HOSPITALS HEALTH SYSTEM 99326645-5fca-49c4-8acb-c927c83e397b Q2 UNIVERSITY HOSPITALS HEALTH SYSTEM 305817 UNIVERSITY HOSPITALS HEALTH SYSTEM 2010 second_quarter MED Medical issues relating to hospitals and physicians S. 353/HR 758 National Pediatric Research Consortium, childhood obesity legislation/activities; House Resolution 996 & Senate Resolution 412 (childhood obesity awareness month for Sept), Child Nutrition Reauthorization Act, S. 3307/H.R. 5504, Patient Centered Outcomes Research Institute sent nomination to GAO, Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   81775 0 0 2010-07-16T12:00:06.983000-04:00
956725 THE PETRIZZO GROUP, INC. d763558f-5401-4eb5-93e8-aecf21a20c0a Q2 THE PETRIZZO GROUP, INC. 305932 BENAROYA RESEARCH INSTITUTE 2010 second_quarter MED Advocated for federal funding in FY 2011 DoD Appropriations bill to develop personalized disease therapies based on genetic phenptype identification and specialized pre-symptomatic therapy for autoimmune disease. Advocated for federal funding in FY 2011 LHHS Appropriations bill for critical multi-project animal care infrastructure. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-16T12:01:12.203000-04:00
957524 PRIME POLICY GROUP 39ed318c-2a1d-40dc-a84d-a9232af5c26a Q2 PRIME POLICY GROUP 400532589 UNIVERSITY OF MIAMI 2010 second_quarter MED S. 693 - A bill to amend the Public Health Service Act to provide grants for the training of graduate medical residents in preventive medicine. S. 733 - A bill to ensure the continued and future availability of life saving trauma health care in the United States and to prevent further trauma center closures and downgrades by assisting trauma centers with uncompensated care costs, core mission services, and emergency needs. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2010-07-16T14:19:36.843000-04:00
957701 BABBAGE COFOUNDER 4b179a51-3a43-4ff5-b321-071b4605cf36 2T BABBAGE COFOUNDER 68478 ALLOSTATIX 2010 second_quarter MED Testing for post-traumatic stress disorder and other chronic illnesses. HOUSE OF REPRESENTATIVES,SENATE     0 1 2010-07-16T14:54:52.483000-04:00
958185 WOMBLE CARLYLE SANDRIDGE & RICE, LLP 0d84a429-da05-4252-8d84-a5baf35f9cee Q2 WOMBLE CARLYLE SANDRIDGE & RICE, LLP 53505 GEOVAX LABS INC 2010 second_quarter MED To raise Congressional awareness regarding the need for an HIV/AIDS vaccine; Ryan White Act reauthorization issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-16T16:45:35.247000-04:00
958189 MARTIN GREEN 07ff2026-70f7-46ff-a6d0-163bb3d5f04e Q2 MARTIN GREEN 400427061 FABIANI & COMPANY ON BEHALF OF OCTANE 2010 second_quarter MED Funding for innovation accelerator programs and conferences. Commerce, Dept of (DOC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Science Foundation (NSF),SENATE,Small Business Administration (SBA)     0 0 2010-07-16T16:47:28.140000-04:00
958252 MARTIN GREEN 38730cf4-e6bd-4b5d-9c1d-f0bf264f556d Q2 MARTIN GREEN 400427061 FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC. 2010 second_quarter MED The Genomics and Personalized Medicine Act of 2007; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-16T16:54:51.577000-04:00
958269 MARTIN GREEN e1e265d9-5874-4924-b69e-2caa236c50e6 Q2 MARTIN GREEN 400427061 FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS 2010 second_quarter MED Funding for drug and platform development Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2010-07-16T16:56:56.843000-04:00
958397 UNIVERSITY OF IOWA 248299ff-f28d-4553-b042-d5c12fbd8c35 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2010 second_quarter MED FY 2010 Appropriations S. 588; H.R. 1093 Residency Caps H.R. 3; S. 5; S. 30 Stem Cell S. 1576 Minority Improvement S. 1066 Medical Affordability Act H. R. 1788, S. 458 False Claims Correction Act S. 484 Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act (H.R. 1548) Prevention Research Centers Resident Physician Shortage Reduction Act of 2009 Health Care Reform (H.R. 3590) Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   110000 0 0 2010-07-16T17:28:41.297000-04:00
958534 BROWNSTEIN HYATT FARBER SCHRECK, LLP fde5f645-fd52-4bde-b930-4e2c35703d44 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 GENWORTH FINANCIAL INC 2010 second_quarter MED Issues affecting long-term care insurance HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,White House Office 90000   0 0 2010-07-16T19:46:35.637000-04:00
958608 BROWNSTEIN HYATT FARBER SCHRECK, LLP 6c5b82f8-f846-4369-8ad8-280cd9d1d23a Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 MOBILE MEDICAL INTERNATIONAL CORPORATION 2010 second_quarter MED Develop partnership with Veterans Administration (VA) to provide mobile surgery units (MSUs) throughout system when VA operating rooms are under construction or renovation, or additional capacity is needed soon, thus saving the VA money and other benefits. SENATE,Veterans Affairs, Dept of (VA) 50000   0 0 2010-07-16T20:50:01.797000-04:00
958740 BROWNSTEIN HYATT FARBER SCHRECK, LLP c811b1b8-1e5f-477c-9c8d-c4e34626d5b9 Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 Z-MEDICA CORPORATION 2010 second_quarter MED Issues relating to hemostatic blood clotting agents HOUSE OF REPRESENTATIVES,SENATE,U.S. International Development Cooperation Agency 60000   0 0 2010-07-16T23:27:22.060000-04:00
958742 BROWNSTEIN HYATT FARBER SCHRECK, LLP cf65cb62-5a00-40be-bd1c-21515d1561be Q2 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ZOLL DATA SYSTEMS 2010 second_quarter MED Issues relating to healthcare IT funding Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-16T23:30:23.530000-04:00
959019 THE PETRIZZO GROUP, INC. 00d6ca40-3e01-421f-9f83-2a24ea646b4e Q2 THE PETRIZZO GROUP, INC. 305932 DESOTO MEMORIAL HOSPITAL, INC. 2010 second_quarter MED Advocated for Congressional support of appeak to FEMA regarding use of grant funding to reinforce the hospitals roof. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-17T14:22:45.720000-04:00
959042 THE PETRIZZO GROUP, INC. b32294fd-a7ed-49e7-8977-f2b61409eac4 Q2 THE PETRIZZO GROUP, INC. 305932 FATE THERAPEUTICS, INC. 2010 second_quarter MED Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2010-07-17T14:29:59.563000-04:00
959102 THE PETRIZZO GROUP, INC. 2408ee15-56eb-4340-9fbb-2ba3471709cb Q2 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2010 second_quarter MED Advocated in support of the 21st Century Cancer ALERT Act (S. 717). HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-17T14:39:29.860000-04:00
959230 THE PETRIZZO GROUP, INC. c033ecae-d219-457a-b513-2faf31acec20 Q2 THE PETRIZZO GROUP, INC. 305932 ORLANDO HEALTH 2010 second_quarter MED As the Pediatric Neuroscience Institute at the Arnold Palmer Hospital for Children continues to align the services provided with the needs of the Central Florida community, this capability was identified as one that could dramatically improve the quality of life of children in the area. To eliminate wait times of 8-10 weeks and provide more advanced imaging services to patients, we are seeking funding to purchase a 3 Tesla MRI, which has substantially greater diagnostic capabilities than the current unit and would benefit all of the key service that support patients. Orlando Healths Childrens Advocacy Center program. Advocate for federal funding that will ensure that the thousands of families that experience child abuse each year in Orange County, Florida are able to access the services needed to help them recover and heal. Funding will be used to sustain existing child advocates and therapists, and other costs, as well as expand the programs capacity to provide services, with the addition of two child advocates and four therapists. This will expand access to vital rehabilitation and recovery services for victims of child abuse. Orlando Healths M.D. Anderson Cancer Center Nano-medicine for Radiation Protection of U.S. Armed Forces. Advocate for federal funding to support a drug discovery program to improve the survival of, provide faster recovery for, and limit or eliminate drug side effects experienced by US military men and women after exposure to high levels of radiation. The funding will be used to create a platform where scientists can study the effect of radiation on nanoparticles with or without cells. Specifically, scientists will identify the form of nanoceria that provides the most effective level of radioprotection. This research will ultimately lead to the development of an effective drug for the treatment of radiation exposure for military personnel who are exposed to high doses of radiation during service to our country. This will be the first feasibility study of the effect of nano-medicine for … HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-17T19:44:34.157000-04:00
959440 CHARLES DOUGHERTY 9eafe71b-729b-440c-a090-99e829af8777 2A CHARLES DOUGHERTY 50284 SACRED HEART HOSPITAL 2010 second_quarter MED Medical Facilities and Expansion HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-18T11:11:01.257000-04:00
959488 STAPLETON & ASSOCIATES, LLC f474b96a-8ee0-46cd-8722-4936f8b70038 Q2 STAPLETON & ASSOCIATES, LLC 40020147 WAKE FOREST SCHOOL OF MEDICINE, INSTITUTE FOR REGENERATIVE MEDICINE 2010 second_quarter MED Regenerative Medicine Department of Defense Appropriations Act, Fiscal Year 2011. National Defense Authorization Act for Fiscal Year 2011. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-18T13:39:30.567000-04:00
959542 BOB MOSS ASSOCIATES 76214249-008e-4e97-8eac-32fa03ae96c5 Q2 BOB MOSS ASSOCIATES 51877 BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH) 2010 second_quarter MED Securing continued federal support for Burnham's medical and scientific research, including the Department of Defense Appropriations Bil for FY11 (not yet introduced). HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-07-18T14:51:59.473000-04:00
959614 DANIELLE ORGAN PETERS 2486ea68-8a35-4d11-80c7-95608ad465df Q2 DANIELLE ORGAN PETERS 400427062 FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS 2010 second_quarter MED Drug development for ocular infections, TBI/stroke related conditions, and HIV Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2010-07-18T17:26:24.230000-04:00
959630 DANIELLE ORGAN PETERS faeb89d4-c5ff-4a64-9f0f-a4ea2f8fbdd8 Q2 DANIELLE ORGAN PETERS 400427062 FABIANI & COMPANY ON BEHALF OF TRIUS THERAPEUTICS 2010 second_quarter MED Antibiotics, BioDefense Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2010-07-18T17:36:30.277000-04:00
959642 DANIELLE ORGAN PETERS 4bd9f9a3-f39f-4629-a466-cb5a0f10e781 Q2 DANIELLE ORGAN PETERS 400427062 FABIANI & COMPANY ON BEHALF OF VARIATION BIOTECHNOLOGIES 2010 second_quarter MED Funding and parnerships with the Department of Defense and Department of Health and Human Services for vaccine research and development Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Natl Institutes of Health (NIH)     0 0 2010-07-18T17:40:32.627000-04:00
959724 THE PETRIZZO GROUP, INC. 4a391ec2-83f3-4e51-b42a-180dc5f28c15 Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE BIOMEDICAL RESEARCH INSTITUTE 2010 second_quarter MED Advocate for federal funding in the FY 2011 Defense Appropriations bill to support next - generation drug development for Leishmaniasis. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-18T19:38:18.123000-04:00
959728 THE PETRIZZO GROUP, INC. fff4a4a9-3c62-463c-8870-833efde3cea4 Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CANCER CARE ALLIANCE 2010 second_quarter MED Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-18T19:40:19.500000-04:00
959731 THE PETRIZZO GROUP, INC. 401b9274-35db-4490-b6ea-384a5d7df07e Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2010 second_quarter MED Advocate for federal funding for GAPPS Project -- Understanding Increased Risk of Preterm Birth and Stillbirth in a Post-Combat Setting. This request is aimed at improving our understanding of factors which contribute to preterm and stillbirths around the world. Specifically, federal funding would examine how and whether poor nutrition, impoverishment, the high stress of living in war-torn areas, and exposure to various toxins and pathogens increase rates of preterm birth and stillbirth rates. This project will provide the U.S. Army with research that will inspire new diagnostics, therapeutics and other innovations to improve birth outcomes and prevent prematurity and stillbirths. This research will extrapolate to a broader range of maternal health conditions as they relate to the priorities of the Department of Defense for warfighter health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-18T19:43:20.843000-04:00
959794 MCDERMOTT WILL & SCHULTE LLP 8edd6131-8b45-4258-a6ea-0dc49ac38084 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2010 second_quarter MED Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-07-18T22:19:54.593000-04:00
959802 MCDERMOTT WILL & SCHULTE LLP 106be29b-0761-43aa-8d4b-fc390637a36d Q2 MCDERMOTT WILL & SCHULTE LLP 24338 MAYO CLINIC 2010 second_quarter MED Address the safety, health and environmental concerns regarding the transport by railroad of hazardous commodities and coal traffic near the Rochester, Minnesota Mayo Clinic facility; more than 30,000 doctors and staff use this facility each day. The multi-year Surface Transportation Authorization Act of 2009 (STAA) and the House THUD Subcommittee 2010 Transportation, Housing and Urban Development Appropriations Bill (H.R. 3288). HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) 45000   0 0 2010-07-18T22:31:58.893000-04:00
959814 MCDERMOTT WILL & SCHULTE LLP 3e56d737-8772-4543-a519-76cb41c8152e Q2 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2010 second_quarter MED FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 250000   0 0 2010-07-18T23:01:06.797000-04:00
959919 VAN SCOYOC ASSOCIATES e7dbd233-a4db-4ab9-bb5d-950de2c3a557 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF NEBRASKA 2010 second_quarter MED Medical and biomedical research programs. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-19T04:59:56.927000-04:00
959964 VAN SCOYOC ASSOCIATES ace2619e-1771-4645-8890-04bb81b89c4e Q2 VAN SCOYOC ASSOCIATES 39837 MOUNT DESERT ISLAND BIOLOGICAL LABORATORY 2010 second_quarter MED Department of Defense Appropriations Act, FY2011, Biomedical research. H.R.5136/S.3454, National Defense Authorization Act, FY2011, Biomedical research. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-19T05:24:17.787000-04:00
960065 VAN SCOYOC ASSOCIATES fa2cd650-d654-451d-868c-9178f611a803 Q2 VAN SCOYOC ASSOCIATES 39837 MEDICINES FOR MALARIA VENTURE 2010 second_quarter MED Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2011, USAID research and development related issues and initiatives. Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, Research and development related issues and initiatives. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) 30000   0 0 2010-07-19T06:21:09.207000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2294.098ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API